- Home
- Publications
- Publication Search
- Publication Details
Title
The clinical mutatome of core binding factor leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-01-03
DOI
10.1038/s41375-019-0697-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients
- (2019) Friederike Christen et al. BLOOD
- Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia
- (2018) Raphael Itzykson et al. BLOOD
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
- (2016) Hartmut Döhner et al. BLOOD
- Comprehensive mutational profiling of core binding factor acute myeloid leukemia
- (2016) N. Duployez et al. BLOOD
- CSF3R mutations have a high degree of overlap with CEBPA mutations in pediatric AML
- (2016) J. E. Maxson et al. BLOOD
- RNA-sequencing analysis of core binding factor AML identifies recurrent ZBTB7A mutations and defines RUNX1-CBFA2T3 fusion signature
- (2016) V.-P. Lavallee et al. BLOOD
- Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia
- (2016) K. H. Metzeler et al. BLOOD
- Mutations in the CCND1 and CCND2 genes are frequent events in adult patients with t(8;21)(q22;q22) acute myeloid leukemia
- (2016) A-K Eisfeld et al. LEUKEMIA
- The genomic landscape of core-binding factor acute myeloid leukemias
- (2016) Zachary J Faber et al. NATURE GENETICS
- ZBTB7A mutations in acute myeloid leukaemia with t(8;21) translocation
- (2016) Luise Hartmann et al. Nature Communications
- Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome
- (2016) C Y Cher et al. Blood Cancer Journal
- Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemia
- (2015) R Sood et al. LEUKEMIA
- Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocations
- (2014) J.-B. Micol et al. BLOOD
- High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome
- (2014) M-T Krauth et al. LEUKEMIA
- Cell Fate Decisions in Malignant Hematopoiesis: Leukemia Phenotype Is Determined by Distinct Functional Domains of the MN1 Oncogene
- (2014) Courteney K. Lai et al. PLoS One
- Exome sequencing identifies recurring FLT3 N676K mutations in core-binding factor leukemia
- (2013) S. Opatz et al. BLOOD
- Prevalence of a new auto-activating colony stimulating factor 3 receptor mutation (CSF3R-T595I) in acute myeloid leukemia and severe congenital neutropenia
- (2013) R. Beekman et al. HAEMATOLOGICA
- MPN patients harbor recurrent truncating mutations in transcription factor NF-E2
- (2013) Jonas S. Jutzi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The importance of relative mutant level for evaluating impact on outcome of KIT, FLT3 and CBL mutations in core-binding factor acute myeloid leukemia
- (2013) C Allen et al. LEUKEMIA
- Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG)
- (2012) P. Paschka et al. BLOOD
- GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia
- (2012) P. A. Greif et al. BLOOD
- Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
- (2012) Lambert Busque et al. NATURE GENETICS
- TET2Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
- (2011) Klaus H. Metzeler et al. JOURNAL OF CLINICAL ONCOLOGY
- A monopartite sequence is essential for p45 NF-E2 nuclear translocation, transcriptional activity and platelet production
- (2010) J. PERDOMO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- AML with CBFB–MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletions
- (2010) C Haferlach et al. LEUKEMIA
- Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia
- (2008) Krzysztof Mrózek et al. CURRENT OPINION IN ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started